Improved Treatment for Primary HIV Infection by Interferon-Alfa Therapy? Does HCV Treatment in HIV/HCV Coinfected Patients Help Us to Test This Hypothesis?

被引：0
|
作者：
zur Wiesch, Julian Schulze [1 ,2 ]
van Lunzen, Jan [1 ,2 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Infect Dis Unit, Dept Internal Med, D-20251 Hamburg, Germany
[2] Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20251 Hamburg, Germany
来源：
JOURNAL OF INFECTIOUS DISEASES | 2013年 / 208卷 / 02期
关键词：
CHRONIC HEPATITIS-C; ANTIRETROVIRAL THERAPY; PLUS RIBAVIRIN; VIRUS; REPLICATION; DNA;
D O I：
10.1093/infdis/jit159
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：362 / 362
页数：1
相关论文
共 50 条
  • [31] Re-treatment of chronic HCV infection in HIV co-infected patients and predictors of sustained viral response
    Krastinova, Evguenia
    Bani-Sadr, Firouze
    Fromentin, Delphine
    Goujard, Cecile
    Hessamfar, Mojgan
    Yazdanpanah, Yazdan
    Pol, Stanislas
    Cacoub, Patrice
    Perronne, Christian
    Carrat, Fabrice
    JOURNAL OF INFECTION, 2014, 68 (05) : 462 - 466
  • [32] Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study
    Garcia-Broncano, Pilar
    Maria Medrano, Luz
    Berenguer, Juan
    Brochado-Kith, Oscar
    Gonzalez-Garcia, Juan
    Jimenez-Sousa, Angeles
    Quereda, Carmen
    Sanz, Jose
    Jesus Tellez, Maria
    Diaz, Laura
    Luis JImenez, Jose
    Resino, Salvador
    Carrero, A.
    Miralles, P.
    Lopez, J. C.
    Parras, F.
    Padilla, B.
    Aldamiz-Echevarria, T.
    Tejerina, F.
    Diez, C.
    Perez-Latorre, L.
    Fanciulli, C.
    Gutierrez, I
    Ramirez, M.
    Carretero, S.
    Bellon, J. M.
    Bermejo, J.
    Berenguer, J.
    Hontanon, V
    Arribas, J. R.
    Montes, M. L.
    Bernardino, I
    Pascual, J. F.
    Zamora, F.
    Pena, J. M.
    Arnalich, F.
    Diaz, M.
    Gonzalez-Garcia, J.
    Domingo, P.
    Guardiola, J. M.
    Van den Eynde, E.
    Perez, M.
    Ribera, E.
    Crespo, M.
    Casado, J. L.
    Dronda, F.
    Moreno, A.
    Perez-Elias, M. J.
    Sanfrutos, M. A.
    Moreno, S.
    JOURNAL OF INFECTION, 2020, 80 (01) : 99 - 110
  • [33] IL28B Polymorphism, Pretreatment CXCL10, and HCV RNA Levels Predict Treatment Response in Racially Diverse HIV/HCV Coinfected and HCV Monoinfected Patients
    Zeremski, Marija
    Dimova, Rositsa B.
    Makeyeva, Jessy
    Sipley, John D.
    Jacobson, Ira M.
    Rennert, Hanna
    Talal, Andrew H.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 63 (01) : 9 - 16
  • [34] Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: A retrospective repeated liver biopsy analysis
    Ingiliz, Patrick
    Valantin, Marc-Antoine
    Preziosi, Paul
    Finzi, Laetitia
    Pais, Raluka
    Fedchuk, Larysa
    Dominguez, Stephanie
    Katlama, Christine
    Poynard, Thierry
    Benhamou, Yves
    JOURNAL OF HEPATOLOGY, 2012, 56 (01) : 49 - 54
  • [35] Peg-interferon and ribavirin treatment in HIV/HCV co-infected patients in Thailand: efficacy, safety and pharmacokinetics
    Smolders, E. J.
    Thammajaruk, N.
    de Kanter, C. T. M. M.
    Colbers, A.
    Chaiyahong, P.
    Cuprasitrut, T.
    Chittmittraprap, S.
    Apornpong, T.
    Khemnark, S.
    Tangkijvanich, P.
    Burger, D. M.
    Avihingsanon, A.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2018, 23 (03) : 295 - 305
  • [36] Pegylated IFN-α2b plus ribavirin for treatment-naive patients coinfected with HCV and HIV
    Mallolas, Josep
    Laguno, Montserrat
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2008, 6 (03) : 281 - 289
  • [37] Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions
    Winnock, M.
    Bani-Sadr, F.
    Pambrun, E.
    Loko, M-A
    Carrieri, P.
    Neau, D.
    Morlat, P.
    Marchou, B.
    Dabis, F.
    Salmon, D.
    HIV MEDICINE, 2013, 14 (07) : 430 - 436
  • [38] IL28B SNP rs8099917 Is Strongly Associated with Pegylated Interferon-α and Ribavirin Therapy Treatment Failure in HCV/HIV-1 Coinfected Patients
    Aparicio, Ester
    Parera, Mariona
    Franco, Sandra
    Perez-Alvarez, Nuria
    Tural, Cristina
    Clotet, Bonaventura
    Angel Martinez, Miguel
    PLOS ONE, 2010, 5 (10):
  • [39] Deciphering the Interleukin 28B Variants That Better Predict Response to Pegylated Interferon-α and Ribavirin Therapy in HCV/HIV-1 Coinfected Patients
    de Castellarnau, Montserrat
    Aparicio, Ester
    Parera, Mariona
    Franco, Sandra
    Tural, Cristina
    Clotet, Bonaventura
    Angel Martinez, Miguel
    PLOS ONE, 2012, 7 (02):
  • [40] A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin
    Reiberger, Thomas
    Payer, Berit A.
    Ferlitsch, Arnulf
    Sieghart, Wolfgang
    Breitenecker, Florian
    Aichelburg, Maximilian C.
    Schmied, Brigitte
    Rieger, Armin
    Trauner, Michael
    Peck-Radosavljevic, Markus
    ANTIVIRAL THERAPY, 2012, 17 (07) : 1327 - 1334
12345